Driving retirement: the role of the physician

Carr, David B.; Meuser, Thomas M.; Morris, John C.
September 2006
CMAJ: Canadian Medical Association Journal;9/12/2006, Vol. 175 Issue 6, p601
Academic Journal
The article presents research which dealt with Alzheimer's disease. The outcome of the research suggests that dementia severity and advanced age are associated with driving cessation. They also identified that level of cognitive impairment and behaviors such as agitation, apathy and hallucinations were found to be important specific predictors of driving retirement in patients with mild-to-moderate dementia.


Related Articles

  • CHAPTER 44: ALZHEIMER'S. Miller, Richard K.; Washington, Kelli D. // Healthcare Business Market Research Handbook;2007, p192 

    Chapter 44 of "The 2006 Healthcare Business Market Research Handbook" is presented. It offers an assessment of the prevalence of Alzheimer's disease in the U.S. The forecast of the Alzheimer's Association on the cases of the disease in 2050 is given. It also reports on the drug treatments for...

  • Cost-effectiveness of memantine compared with standard care in moderate-to-severe Alzheimer disease in Canada. Gagnon, Micheline; Rive, Benoit; Hux, Margaret; Guilhaume, Chantal; Rive, BenoĆ®t // Canadian Journal of Psychiatry;Aug2007, Vol. 52 Issue 8, p519 

    Objective: To conduct a cost-effectiveness analysis comparing the addition of memantine to standard care (that is, without acetylcholinesterase inhibitors) with standard care alone in moderate-to-severe Alzheimer disease (AD) in Canada.Methods: A 2-year Markov model...

  • RESEARCH & TECHNOLOGY.  // MondayMorning;3/24/2014, Vol. 22 Issue 11, p6 

    The article cites several medical research studies. One study is from Harvard University on Alzheimer's disease suggests that memory and thinking problems of the disease and other dementias may be related to a failure in the brain's stress response system. Second study is by Melbourne Brain...

  • Meadow Place Focused Entirely On Alzheimer's. Payne, Scott // Grand Rapids Business Journal;9/15/2003, Vol. 21 Issue 37, pB6 

    Features the Meadow Place, a facility dedicated to the care of Alzheimer's sufferers in Michigan. Major problem in the life of an Alzheimer's patient from a layman's perspective, Jean Van Den Beldt; Inspiration to build the facility; Amenities offered for residents.

  • Neurodegenerative disease: Death receptor takes centre stage. Whalley, Katherine // Nature Reviews Neuroscience;Oct2007, Vol. 8 Issue 10, p740 

    The article reports on the pathology of Alzheimer's disease with emphasis on the results of various studies being conducted in order to find effective treatment methods. According to the author, there has been no concrete understanding of the pathology of the disease; as a matter of fact, a...

  • CHAPTER 59: ALZHEIMER'S. Miller, Richard K.; Washington, Kelli D. // Healthcare Business Market Research Handbook;2006, p330 

    Chapter 59 of the book "The 2006 Healthcare Business Market Research Handbook" is presented. It reveals the cost of diagnosis, treatment and long-term care for patients with Alzheimer's disease in the U.S., according to the Alzheimer's Association. The number of people diagnosed with Alzheimer's...

  • Care of Individuals With Alzheimer's Disease In the New Millennium. Souder, Elaine; Rapp, Carla Gene; Davis, Gwynn V.; Beck, Cornelia; Liem, Pham H. // MEDSURG Nursing;Feb2004, Vol. 13 Issue 1, p22 

    The incidence of Alzheimer's disease (AD), the leading form of dementia, is expected to increase exponentially in the next 50 years. The nursing and medical care of individuals diagnosed with AD, including the health-related challenges faced by all aging individuals, are discussed.

  • Independent Nurse: Journals Watch - Daffodils good for the memory.  // GP: General Practitioner;11/11/2005, p85 

    The article reports that scientists at Cardiff University, Cardiff, Wales, believe that mountain varieties of their national flower could be used to manufacture a treatment for Alzheimer's disease.

  • Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease? Farlow, Martin R. // Alzheimer's Research & Therapy;2010, Vol. 2 Issue 3, p1 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics